No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Adult
-
Aminopyridines / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Benzimidazoles / adverse effects
-
Humans
-
Lymphoma, Mantle-Cell* / drug therapy
-
Neoplasm Recurrence, Local / drug therapy
-
Recurrence
-
Treatment Outcome
Substances
-
Aminopyridines
-
Benzimidazoles
-
abemaciclib
Grants and funding
Funding: this study was funded by Eli Lilly and company.